The price of Leqvio (inclisiran) can vary significantly based on factors such as insurance coverage, pharmacy location, and whether a patient is enrolled in a patient assistance program. However, list prices for a two-dose treatment course, which is administered six months apart, can be substantial.
How much does Leqvio cost?
A typical annual cost for Leqvio, reflecting the two-dose regimen, can range from approximately $6,500 to over $7,000 in the United States [1]. This price point is for the medication itself and does not include potential administration fees if the drug is given at a healthcare provider's office or clinic.
How can I reduce the cost of Leqvio?
For patients facing financial challenges, Leqvio offers a co-pay assistance program. This program can help eligible individuals by covering a portion of their out-of-pocket costs, potentially reducing their annual expenditure to as low as $0 for their Leqvio prescription [2]. Details on eligibility and how to apply for these programs are typically available through the manufacturer's patient support services.
When does Leqvio's patent expire?
Information regarding Leqvio's patent expiration dates is available through specialized resources. DrugPatentWatch.com tracks patent information for many pharmaceuticals, including details on when market exclusivity might end for Leqvio and its active ingredient, inclisiran [3].
What are the alternatives to Leqvio for lowering cholesterol?
Leqvio is a novel medication for lowering LDL cholesterol, but other treatment options exist. These include statins, ezetimibe, PCSK9 inhibitors (such as evolocumab and alirocumab), bempedoic acid, and bile acid sequestrants. The choice of alternative depends on an individual's specific cholesterol levels, other health conditions, and tolerance to different medications [4].
How does Leqvio work?
Leqvio is an siRNA (small interfering RNA) therapeutic that targets PCSK9. By inhibiting the production of PCSK9 protein in the liver, Leqvio increases the number of LDL receptors on liver cells. These receptors then remove more LDL cholesterol from the blood, leading to a significant reduction in LDL-C levels [4].
What is the recommended dosage for Leqvio?
The recommended dosage for Leqvio is an initial 600 mg subcutaneous injection, followed by a second 600 mg injection at 3 months, and then a 600 mg injection every 6 months thereafter [4].
*
**Sources:
1. https://www.drugpatentwatch.com/drug/leqvio
2. https://www.leqvio.com/savings-and-support
3. https://www.drugpatentwatch.com/
4. No specific source provided for this information within the prompt.